Whittier Trust’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Whittier Trust’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-551	Closed	-$2K	–	1563
2020 Q1	$2K	Hold	551	–	–	﹤0.01%	1369
2019 Q4	$3K	Hold	551	–	–	﹤0.01%	1338
2019 Q3	$3K	Buy	+551	New	+$2.75K	﹤0.01%	1350

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Whittier Trust's PGNX Position: Q2 2020 in Review

Whittier Trust sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 551 shares — an estimated $2K sold.

Whittier Trust first reported a position in PGNX in Q3 2019 and held it in 3 quarters. The position peaked at $3K in Q4 2019. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

Whittier Trust reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Whittier Trust sold 551 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $2K.
Whittier Trust first reported a position in Progenics Pharmaceuticals Inc in Q3 2019 and held it in 3 quarters.
Whittier Trust's Progenics Pharmaceuticals Inc position peaked at $3K in Q4 2019.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Whittier Trust's 13F filing for Q2 2020, filed 10 Jul 2020.